1. Home
  2. MTLS vs BNTC Comparison

MTLS vs BNTC Comparison

Compare MTLS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTLS
  • BNTC
  • Stock Information
  • Founded
  • MTLS 1990
  • BNTC 1995
  • Country
  • MTLS Belgium
  • BNTC United States
  • Employees
  • MTLS N/A
  • BNTC N/A
  • Industry
  • MTLS Computer Software: Prepackaged Software
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTLS Technology
  • BNTC Health Care
  • Exchange
  • MTLS Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • MTLS 349.7M
  • BNTC 335.5M
  • IPO Year
  • MTLS 2014
  • BNTC N/A
  • Fundamental
  • Price
  • MTLS $5.13
  • BNTC $13.24
  • Analyst Decision
  • MTLS
  • BNTC Strong Buy
  • Analyst Count
  • MTLS 0
  • BNTC 5
  • Target Price
  • MTLS N/A
  • BNTC $26.00
  • AVG Volume (30 Days)
  • MTLS 127.2K
  • BNTC 40.8K
  • Earning Date
  • MTLS 10-23-2025
  • BNTC 09-25-2025
  • Dividend Yield
  • MTLS N/A
  • BNTC N/A
  • EPS Growth
  • MTLS N/A
  • BNTC N/A
  • EPS
  • MTLS 0.11
  • BNTC N/A
  • Revenue
  • MTLS $311,850,851.00
  • BNTC N/A
  • Revenue This Year
  • MTLS $2.98
  • BNTC N/A
  • Revenue Next Year
  • MTLS $7.09
  • BNTC N/A
  • P/E Ratio
  • MTLS $48.31
  • BNTC N/A
  • Revenue Growth
  • MTLS 2.98
  • BNTC N/A
  • 52 Week Low
  • MTLS $3.93
  • BNTC $8.06
  • 52 Week High
  • MTLS $9.69
  • BNTC $17.15
  • Technical
  • Relative Strength Index (RSI)
  • MTLS 47.90
  • BNTC 59.72
  • Support Level
  • MTLS $5.01
  • BNTC $12.57
  • Resistance Level
  • MTLS $5.32
  • BNTC $13.33
  • Average True Range (ATR)
  • MTLS 0.18
  • BNTC 0.60
  • MACD
  • MTLS 0.02
  • BNTC 0.10
  • Stochastic Oscillator
  • MTLS 52.08
  • BNTC 95.59

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: